KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerence (CRNC) Gains from Sales and Divestitures (2019 - 2025)

Cerence's Gains from Sales and Divestitures history spans 7 years, with the latest figure at $1.1 million for Q1 2025.

  • For Q1 2025, Gains from Sales and Divestitures fell 13.65% year-over-year to $1.1 million; the TTM value through Mar 2025 reached $1.1 million, down 13.65%, while the annual FY2024 figure was $1.3 billion, 130968.96% up from the prior year.
  • Gains from Sales and Divestitures reached $1.1 million in Q1 2025 per CRNC's latest filing, up from $143369.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.3 billion in Q3 2024 to a low of $143369.0 in Q4 2024.
  • Average Gains from Sales and Divestitures over 5 years is $75.4 million, with a median of $955286.0 recorded in 2021.
  • The largest YoY upside for Gains from Sales and Divestitures was 130968.96% in 2024 against a maximum downside of 80.9% in 2024.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $806660.0 in 2021, then crashed by 30.12% to $563692.0 in 2022, then skyrocketed by 33.19% to $750776.0 in 2023, then tumbled by 80.9% to $143369.0 in 2024, then soared by 642.16% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRNC's Gains from Sales and Divestitures are $1.1 million (Q1 2025), $143369.0 (Q4 2024), and $1.3 billion (Q3 2024).